All
'Pre-biologics' not necessarily prehistoric
June 1st 2005Aat the recent annual meeting of the American Academy of Dermatology, there was a coronation of sorts. The biologic agents officially ascended to the status of treatment of choice for moderate-to-severe psoriasis. Several prominent dermatologists spoke on the subject and hailed these new agents as superior to old-fashioned remedies, which have now been dubbed "pre-biologics." Am I being too sensitive if I feel somewhat prehistoric when others label as pass? therapies that I use and upon which I routinely depend?
Medicare woes add to practice difficulties
June 1st 2005Should the cuts take place as planned, 18 percent of physicians surveyed by the American Medical Association say they would stop accepting new Medicare patients; 57 percent would decrease time spent with patients; and 46 percent would reduce staffing levels.
Chemical peels still have role
May 1st 2005New Orleans — Although laser cosmetic procedures have captured popular attention, chemical peels continue to be appropriate for many patients, according to Suzan Obagi, M.D., at the annual cosmetic surgery symposium of the American College of Oral and Maxillofacial Surgeons.
Chemical peels still have role
May 1st 2005New Orleans — Although laser cosmetic procedures have captured popular attention, chemical peels continue to be appropriate for many patients, according to Suzan Obagi, M.D., at the annual cosmetic surgery symposium of the American College of Oral and Maxillofacial Surgeons.
Rhythmic changes influence female skin susceptibility
May 1st 2005Orlando, Fla. — Fluctuations in estrogen and progesterone during the menstrual cycle can cause changes to the reproductive system, yet little attention has been paid to how these variations may impact the body's largest organ, the skin.
Mosquito abatement, effective repellents key to eradicating West Nile Virus
May 1st 2005Newport Beach, Calif. — The West Nile Virus outbreak in New York City in 1999 provided important lessons in prevention, abatement and repellent use. The New York area health departments quickly began public health programs, according to Tissa R. Hata, M.D., speaking at the Pacific Dermatology Meeting, here.
New class of UV absorbers emerging
May 1st 2005New Orleans — An emerging new class of organic, insoluble UV absorbers shows promise in providing improved broad-spectrum UVB and UVA sunscreen protection and meets the increasing demand of consumers and dermatologists, according to chemist Uli Osterwalder. He reports that the first representative of this UV absorber — bisoctrizole — has been used in sunscreens in European countries for five years and is now being submitted to the U.S. Food and Drug Administration (FDA) for approval.
Skin regeneration through growth hormone factors
May 1st 2005Tokyo — Growth factors offer seemingly endless potential to skin wound repair and regeneration, yet there are several questions surrounding those that are exogenously applied to acute or chronic skin wounds, according to Xiaobing Fu, M.D., professor, Wound Healing and Cell Biology Laboratory, Burns Institute, The General Hospital of PLA, Beijing, China.
Tacrolimus, UVB therapy synergistic duo
May 1st 2005Nice, France — Results of a comparative, prospective, randomized study undertaken by French dermatologists indicate that topical tacrolimus ointment 0.1 percent (Protopic, Fujisawa) plus phototherapy with a 308-nm excimer laser can be a highly effective combination for the treatment of recalcitrant, localized vitiligo.
SD doxycycline: New rosacea therapeutic option
May 1st 2005New Orleans — Results of a multicenter phase 3, randomized, double-blind, placebo-controlled trial demonstrate the safety and efficacy of a subantimicrobial-dose (SD) of doxycycline for the treatment of rosacea, said Diane M. Thiboutot, M.D., at the 63rd Annual Meeting of the American Academy of Dermatology here.
West Nile virus skin symptoms documented
May 1st 2005New Orleans — Scientific literature rarely portrays cutaneous manifestations of West Nile virus (WNV) because these manifestations are, by nature, transient. However, a recent case report contains what is only the second publication of these symptoms.